RecruitingNot ApplicableNCT06675240

Meditative Neurofeedback for Depression

Sponsor

University of California, San Diego

Enrollment

27 participants

Start Date

Nov 15, 2024

Study Type

INTERVENTIONAL

Conditions

Depression - Major Depressive Disorder Depression Disorders

Summary

The goal of this open-label single-arm study is to test a meditative neurofeedback intervention for depressed mood.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new approach called meditative neurofeedback as a treatment for depression. Neurofeedback trains people to regulate their own brain activity in real time using visual or audio signals, and this study combines that with meditative practices to target mood regulation. **You may be eligible if...** - You are experiencing moderate depression based on a standard questionnaire (PHQ-9) **You may NOT be eligible if...** - You have an active substance abuse or dependence problem - You have a psychotic disorder (such as schizophrenia) - You have bipolar disorder - You are currently experiencing acute suicidal behavior Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALMediNF

Over 10-sessions participants will engage in a breath-focused meditative practice with frontal brain connectivity neurofeedback provided to enhance performance.